Sichenzia Ross Ference Kesner LLP Represents A.G.P/ Alliance Global Partners (through Euro Pacific Capital) in $8 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.
Press Release – New York, NY – May 3rd, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented A.G.P./Alliance Global Partners, offering securities through Euro Pacific Capital, in an underwritten public offering of shares of common stock of Cocrystal Pharma, Inc. (NASDAQ: COCP). Cocrystal sold an aggregate of 4,210,527 shares of common stock at a price of $1.90 per share. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. The Sichenzia Ross Ference Kesner LLP team was led by partners Marc Ross, Avital Perlman and Tom Rose.